NOVARTIS AG Quarterly Research And Development Expense in USD from Q2 2017 to Q2 2024

Taxonomy & unit
ifrs-full: USD
Summary
Novartis Ag annual/quarterly Research And Development Expense history and growth rate from Q2 2017 to Q2 2024.
  • Novartis Ag Research And Development Expense for the quarter ending June 30, 2024 was $2.37B, a 2.73% increase year-over-year.
  • Novartis Ag annual Research And Development Expense for 2024 was $10B, a 11.9% decline from 2023.
  • Novartis Ag annual Research And Development Expense for 2023 was $11.4B, a 24% increase from 2022.
  • Novartis Ag annual Research And Development Expense for 2022 was $9.17B, a 6.15% increase from 2021.
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.37B +$63M +2.73% Apr 1, 2024 Jun 30, 2024 6-K 2024-07-18
Q2 2023 $2.3B -$194M -7.77% Apr 1, 2023 Jun 30, 2023 6-K 2024-07-18
Q2 2022 $2.5B +$98M +4.08% Apr 1, 2022 Jun 30, 2022 6-K 2023-07-18
Q2 2021 $2.4B -$41M -1.68% Apr 1, 2021 Jun 30, 2021 6-K 2022-07-19
Q2 2020 $2.44B +$390M +19% Apr 1, 2020 Jun 30, 2020 6-K 2021-07-21
Q2 2019 $2.05B -$75M -3.53% Apr 1, 2019 Jun 30, 2019 6-K 2020-07-21
Q2 2018 $2.13B +$64M +3.1% Apr 1, 2018 Jun 30, 2018 6-K 2019-07-18
Q2 2017 $2.06B Apr 1, 2017 Jun 30, 2017 6-K 2018-07-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.